Invesco Ltd.

Position in ABSI — Absci Corp

CIK 914208 Atlanta, GA

Position in ABSI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,315,772

+$5,985,412 QoQ

Shares Held

544,933

+394.9% QoQ

Ownership

0.318%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 195 holders

Holding Since

Mar 2022

14 quarters on record

Voting authority Sole 0% Shared 99% None 1%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. ABSI ranks #68 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,315,772	544,933	+394.9%	Shares	Defined	2026-08-14
2026-03-31	$330,360	110,120	+101.9%	Shares	Defined	2026-05-12
2025-12-31	$190,378	54,550	+14.3%	Shares	Defined	2026-02-19
2025-09-30	$145,080	47,724	+6.1%	Shares	Defined	2025-11-13
2025-06-30	$115,638	44,996	+6.5%	Shares	Defined	2025-08-13
2025-03-31	$106,069	42,259	-2.9%	Shares	Defined	2025-05-12
2024-12-31	$114,061	43,535	+15.1%	Shares	Defined	2025-02-13
2024-09-30	$144,456	37,816	-0.2%	Shares	Defined	2024-11-12
2024-06-30	$116,731	37,900	+129.5%	Shares	Defined	2024-08-13
2023-03-31	$28,902	16,516	-6.9%	Shares	Defined	2023-05-12
2022-12-31	$37,262	17,744	-0.9%	Shares	Defined	2023-02-13
2022-09-30	$56,017	17,897	-0.6%	Shares	Defined	2022-11-14
2022-06-30	$59,749	17,997	+57.0%	Shares	Defined	2022-08-15
2022-03-31	$96,607	11,460	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.